Medicinova Inc
MNOVNasdaqCIK 1226616HealthcareFiscal year ends Dec 31
Reports and events: 299 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2917:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-104738 |
| 2026-09-2816:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-405318 |
| 2026-09-0207:30 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-379348 |
| 2026-08-1907:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-356146 |
| 2026-08-1316:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349323 |
| 2026-06-2416:38 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-281171 |
| 2026-05-1416:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224066 |
| 2026-04-2916:26 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001193125-26-191866 |
| 2026-03-1017:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-100432 |
| 2026-02-2006:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-060232 |
| 2025-12-3007:53 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-335917 |
| 2025-11-1216:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277779 |
| 2025-08-2216:22 ET | S-1 | Registration statement | 0001193125-25-186446 |
| 2025-08-1417:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-109041 |
| 2025-08-0119:49 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-170744 |
| 2025-06-1816:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-087924 |
| 2025-05-1316:39 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070461 |
| 2025-04-2816:15 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0000950170-25-059321 |
| 2025-03-1116:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051990 |
| 2025-02-1916:55 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-023301 |
| 2024-11-1316:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126343 |
| 2024-08-0816:32 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094092 |
| 2024-06-1216:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-072461 |
| 2024-05-0916:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056996 |
| 2024-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0000950170-24-049146 |
| 2024-04-0116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-083356 |
| 2024-02-1516:25 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-015920 |
| 2023-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062079 |
| 2023-08-0916:17 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040621 |
| 2023-08-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-204956 |
| 2023-06-2216:30 ET | 8-K | 3.01 Delisting notice | 0001193125-23-172585 |
| 2023-06-1420:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-027823 |
| 2023-05-1116:19 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021279 |
| 2023-04-2616:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-118572 |
| 2023-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2023-06-13 | 0000950170-23-014814 |
| 2023-03-2816:16 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0000950170-23-010297 |
| 2023-02-1616:15 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-003054 |
| 2022-11-1016:19 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-037391 |
| 2022-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-029126 |
| 2022-07-1212:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-22-038767 |
| 2022-06-2116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-177628 |
| 2022-06-1517:16 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-023341 |
| 2022-05-1216:17 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019872 |
| 2022-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2022-06-14 | 0001564590-22-015688 |
| 2022-04-0518:01 ET | 8-K | 8.01 Other events | 0001193125-22-095275 |
| 2022-02-1616:26 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-005388 |
| 2021-11-1206:03 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056378 |
| 2021-08-1216:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043988 |
| 2021-08-0216:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-233293 |
| 2021-07-2316:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-21-222985 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:11 ET. Listed shows no prices and gives no investment advice.